Research
The La Trobe Institute for Molecular Science (LIMS) continues to build on its strengths to take advantage of new technologies in Biosensors, Synthetic Biology, Digital Biology and Space Biology, and apply them to seek new solutions to cancer, cardiovascular health, and infection and immunity areas.
As well as conducting research across three of La Trobe University's campuses, LIMS hosts three embedded biotech companies:
Cancer
The Cancer theme investigates the mechanisms of cancer initiation and progression, the crosstalk between cancer cells and the surrounding environment, and the potential of novel therapeutic approaches for combating disease.
Infection and Immunity
The Infection and Immunity theme studies the molecules used by viruses, bacteria, parasites and fungi to infect humans, animals and plants, and the immune response associated with this.
Synthetic Biology
Developing CRISPR, mRNA, nucleotide and peptide technologies to design tailored immune cells and microbiomes for personalised preventative and recovery interventions.
Biosensors
Developing, refining and applying novel, cutting-edge biosensor technologies to revolutionise health monitoring and disease detection in real time, anywhere.
Space Biology
Utilising the unique challenges of space as a test bed for robust and universally deployable health and technological solutions.
Digital Biology
Applying advanced machine learning techniques and data analysis tools to better understand biological systems and enhance disease prediction and prevention.
Cardiovascular Biology
Exploring abnormalities of the heart and blood vessels to understand the underlying pathologies and risk factors of heart attack and stroke.
Research Centres
LIMS is home to three of La Trobe University's Research Centres, spanning cardiovascular research, extracellular vesicles research, and biosensors research.